Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Cardiology ClinicsReferences
- Pulmonary hypertension due to left heart disease.Circulation. 2012; 126: 975-990
- Pulmonary hypertension associated with left heart disease: updated recommendations of the Cologne Consensus Conference 2018.Int J Cardiol. 2018; 272: 53-62
- Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient.JACC Heart Fail. 2015; 3: 424-425
- Pulmonary hypertension due to left heart disease.Eur Respir J. 2019; 53: 1801897
- 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J. 2016; 37: 2129-2200
- Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum.J Am Coll Cardiol. 2016; 68: 368-378
- Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2018; 20: 16-37
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.Eur Heart J. 2015; 46: ehv317
- Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.Eur Respir J. 2009; 34: 888-894
- Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.Eur Respir J. 2018; 51: 1701197
- Reduced right ventricular output reserve in patients with systemic sclerosis and mildly elevated pulmonary artery pressures.Arthritis Rheumatol. 2019; 71: 805-816
- Mild elevation of pulmonary arterial pressure as a predictor of mortality.Am J Respir Crit Care Med. 2018; 197: 509-516
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J. 2019; 53: 1801913
- Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension.Eur J Heart Fail. 2015; 17: 74-80
- Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.JACC Heart Fail. 2013; 1: 290-299
- Left ventricular heart failure and pulmonary hypertension.Eur Heart J. 2016; 37: 942-954
- Left atrium in heart failure with preserved ejection fraction: structure, function, and significance.Circ Heart Fail. 2014; 7: 1042-1049
- Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.Circ Heart Fail. 2015; 8: 295-303
- Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure).Eur J Heart Fail. 2009; 11: 929-936
- Plasma surfactant protein-B: a novel biomarker in chronic heart failure.Circulation. 2004; 110: 1091-1096
- Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases.Am J Respir Crit Care Med. 2011; 183: 1092-1102
- Diastolic pulmonary vascular pressure gradient.Chest. 2013; 143: 758-766
- Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice.Hypertension. 2012; 59: 1170-1178
- Pulmonary hypertension in heart failure.J Am Coll Cardiol. 2017; 69: 1718-1734
- Preoperative pulmonary hypertension and its impact on survival after heart transplantation.Scand Cardiovasc J. 2014; 48: 47-58
- Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.Circulation. 2012; 125: 289-297
- The relationship between the right ventricle and its load in pulmonary hypertension.J Am Coll Cardiol. 2017; 69: 236-243
- Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure.Chest. 2014; 145: 1064-1070
- Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction.JACC Heart Fail. 2015; 3: 467-474
- The critical role of pulmonary arterial compliance in pulmonary hypertension.Ann Am Thorac Soc. 2016; 13: 276-284
- Right atrial and ventricular adaptation to chronic right ventricular pressure overload.Circulation. 2005; 112: I212-I218
- Imaging the right heart pulmonary circulation unit: Insights from advanced ultrasound techniques.Echocardiography. 2017; 34: 1216-1231
- Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure.Am J Cardiol. 1984; 54: 596-599
- Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.J Am Coll Cardiol. 1995; 25: 1143-1153
- Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.Am J Cardiol. 2000; 85: 837-842
- Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.Eur J Heart Fail. 2017; 19: 873-879
- General measures and supportive therapy for pulmonary arterial hypertension: updated recommendations from the Cologne Consensus Conference 2018.Int J Cardiol. 2018; 272: 30-36
- The influence of age on hemodynamic parameters during rest and exercise in healthy individuals.JACC Heart Fail. 2017; 5: 337-346
- Pulmonary hypertension in heart failure with preserved ejection fraction.Circulation. 2011; 124: 164-174
- Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.Eur Heart J. 2015; 36: 2565-2573
- Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.Eur Heart J. 2018; 39: 1255-1264
- Macitentan in pulmonary hypertension due to left ventricular dysfunction.Eur Respir J. 2018; 51: 1701886
- Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).Respir Res. 2018; 19: 258
- Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Int J Cardiol. 2015; 195: 19-26
- Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.Circulation. 2013; 128: 502-511
- Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial.Wien Klin Wochenschr. 2016; 128: 882-889
- Risk stratification for in-hospital mortality in acutely decompensated heart failure classification and regression tree analysis.JAMA. 2005; 293: 572
- Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.Circ Heart Fail. 2014; 7: 935-944
- Reference ranges for and determinants of right ventricular area in healthy adults by two-dimensional echocardiography.Respiration. 2015; 89: 284-293
- Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.Eur J Heart Fail. 2016; 18: 226-241
- Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study.Eur J Heart Fail. 2010; 12: 382-388
- Transcatheter mitral-valve repair in patients with heart failure.N Engl J Med. 2018; 379: 2307-2318
- Percutaneous repair or medical treatment for secondary mitral regurgitation.N Engl J Med. 2018; 379: 2297-2306
- Percutaneous repair of secondary mitral regurgitation--a tale of two trials.N Engl J Med. 2018; 379: 2374-2376
- 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur J Heart Fail. 2016; 18: 891-975
- Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension.Dtsch Med Wochenschr. 2016; 141: S42-S47
- Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: updated recommendations from the Cologne Consensus Conference 2018.Int J Cardiol. 2018; 272: 46-52
- Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.Am J Respir Crit Care Med. 2011; 184: 1114-1124
- Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.Circulation. 2006; 114: 1482-1489
- The Right Heart International Network (RIGHT-NET): rationale, objectives, methodology, and clinical implications.Heart Fail Clin. 2018; 14: 443-465
- Principles of rehabilitation and reactivation: pulmonary hypertension.Respiration. 2015; 89: 265-273
- Exercise training and rehabilitation in pulmonary hypertension.Heart Fail Clin. 2018; 14: 425-430
- ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.Eur Respir J. 2019; 53: 1800332
- Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction.JAMA. 2016; 315: 36
Article Info
Footnotes
This article originally appeared in Heart Failure Clinics, Volume 16, Issue 1, January 2020.
Disclosure Statement: Dr A.-M. Marra received an institutional grant from Italian Healthcare Ministry (Ricerca Finalizzata per Giovani Ricercatori. Progetto n. GR-2016-02364727). The other authors have nothing to disclose.